AppLovin (APP) stock jumps 5% into next week as Wells Fargo lifts target and CPI looms
10 January 2026

AppLovin (APP) stock jumps 5% into next week as Wells Fargo lifts target and CPI looms

New York, Jan 10, 2026, 16:27 EST — Market closed

  • AppLovin shares climbed roughly 5% on Friday, closing near $647.72
  • Wells Fargo boosted its price target to $735 while maintaining an Overweight rating
  • Tuesday’s U.S. CPI report will serve as the next key macro checkpoint for growth stocks sensitive to rate shifts

AppLovin shares jumped roughly 5% in the last session, closing Friday around $647.72 after moving between about $612 and $650.

The rebound is significant since the stock is caught between two forces: ad demand trends and shifts in interest-rate expectations. Inflation figures due next week could shake Treasury yields, which in turn influence appetite for high-growth stocks.

For AppLovin, the immediate focus isn’t on launching new products but on whether demand stays strong in mobile and web advertising—and how that will affect guidance. Traders have been quick to sell off and just as fast to sell into any rallies.

Wells Fargo’s Alec Brondolo bumped his price target on AppLovin to $735 from $721 on Thursday, maintaining an Overweight rating that suggests the stock could outperform peers. According to a note reported by TheFly, the upgrade comes with raised Q4 revenue forecasts driven by strong mobile game data. However, the firm cautioned that “web ads trends are mixed” and flagged first-quarter consensus as “a high bar.” TipRanks

The stock’s rise coincided with U.S. markets hitting record levels following data that revealed slower job growth in December and a drop in the unemployment rate to 4.4%, which helped maintain hopes for rate cuts.

AppLovin offers software and advertising solutions designed to help firms engage and monetize their audiences. The company also manages a collection of owned apps. Its lineup includes AppDiscovery, MAX, Adjust, Wurl, and Axon Ads Manager, per Reuters company data.

Heading into the next session, investors will watch closely for evidence that mobile advertising demand continues to grow. They’ll also want to see if the company can keep pushing beyond gaming without sacrificing pricing or returns. A shift in tone on web advertising could trigger a sharp reaction.

The next major data point on the macro front is Tuesday’s U.S. Consumer Price Index report for December, set for release at 8:30 a.m. ET. As the government’s key inflation metric, a stronger-than-expected CPI could drive yields higher and weigh on pricey tech and ad-tech stocks.

Technicals are clear-cut. Friday’s peak near $650 now acts as a short-term cap, with the previous session’s low around $613 serving as the first solid support.

But the setup works both ways. Wells Fargo called it a “tough setup,” and AppLovin’s upcoming guidance could weigh on the stock if the company signals caution on first-quarter demand or if ad spending slows amid changing rate forecasts.

AppLovin is set to release its fourth-quarter and full-year 2025 results on Feb. 11, right after the U.S. markets close. The company’s CEO Adam Foroughi and CFO Matthew Stumpf will then hold a webcast at 5 p.m. ET to discuss the numbers.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 88 / 100
#5 BUY THE RESET

Ferguson

NYSE: FERG 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Abbott Laboratories stock drifts into earnings after Canada widens Libre 3 Plus coverage
Previous Story

Abbott Laboratories stock drifts into earnings after Canada widens Libre 3 Plus coverage

Shell stock in focus for Monday as Venezuela sanctions could ease “next week” and buybacks roll on
Next Story

Shell stock in focus for Monday as Venezuela sanctions could ease “next week” and buybacks roll on